Evidence map›Paper›PMID 38756173›Full record

ArticleHealth affairs scholar2024

Locations and characteristics of pharmacy deserts in the United States: a geospatial study.

Rachel Wittenauer, Parth D Shah, Jennifer L Bacci, Andy Stergachis

Abstract read
In one paragraph

Article in Health affairs scholar, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Health disparities in neurology.Nature reviews. Neurology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Macro- and micro-influencers of antimicrobial costs…What do stewardship programs need to know?Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rachel WittenauerCHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA 98195, United States.ORCID https://orcid.org/0000-0002-6606-8708
Parth D ShahHutchinson Institute for Cancer Outcomes Research (HICOR), Fred Hutchinson Cancer Center, Seattle, WA 98109, United States.ORCID https://orcid.org/0000-0002-3536-6219
Jennifer L BacciCHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA 98195, United States.ORCID https://orcid.org/0000-0001-9944-6050
Andy StergachisCHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA 98195, United States.ORCID https://orcid.org/0000-0003-0057-6627

Funding

Scientific/Technical CoreP2CHD042828 · NICHD · UNIVERSITY OF WASHINGTON · PI SARA R. CURRAN · 2017 to 2026
$6.3M
NICHD NIH HHS P2C HD042828
6 · The paper itself

Abstract

Pharmacies are important health care access points, but no national map currently exists of where pharmacy deserts are located. This cross-sectional study used pharmacy address data and Census Bureau surveys to define pharmacy deserts at the census tract level in all 50 US states and the District of Columbia. We also compared sociodemographic characteristics of pharmacy desert vs non-pharmacy desert communities. Nationally, 15.8 million (4.7%) of all people in the United States live in pharmacy deserts, spanning urban and rural settings in all 50 states. On average, communities that are pharmacy deserts have a higher proportion of people who have a high school education or less, have no health insurance, have low self-reported English ability, have an ambulatory disability, and identify as a racial or ethnic minority. While, on average, pharmacies are the most accessible health care setting in the United States, many people still do not have access to them. Further, the people living in pharmacy deserts are often marginalized groups who have historically faced structural barriers to health care. This study demonstrates a need to improve access to pharmacies and pharmacy services to advance health equity.

Indexed as

pharmaco-equitypharmacy accesspharmacy desertpharmacy health services

Identifiers

PMID38756173
PMCPMC11034534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.